Bowhay Ben, Williams Craig A, Gibbons Michael A, Scotton Chris J, Tomlinson Owen W
Clinical & Biomedical Sciences, University of Exeter, Exeter, England, UK.
Academic Department of Respiratory Medicine, Royal Devon University Healthcare NHS Foundation Trust, Exeter, England, UK.
NIHR Open Res. 2025 Jul 4;4:51. doi: 10.3310/nihropenres.13706.2. eCollection 2024.
This review aims to identify which cardiopulmonary exercise test (CPET) derived variables can be used to personalise pulmonary rehabilitation (PR) for people with interstitial lung diseases. A 'one size fits all' approach does not benefit every patient due to a multitude of unique characteristics, subsets and phenotypes. No ILD-specific, tailored pulmonary rehabilitation guidelines exist in this area and exercise programme development is lacking. This leads to wide variation in the success within the literature and clinical practice.
MEDLINE, Embase, CINAHL, SPORTDiscus and the Cochrane Database of Systematic Reviews will be searched to identify studies that utilise CPET variables for PR development. Quality assessment is to be performed using the Critical Appraisal Skills Program (CASP) checklists for single cohort studies and randomised controlled studies.
The primary outcomes found within the included studies for peak volume of oxygen consumption (VO ), work rate (WR ), oxygen consumption at anaerobic threshold (VO -AT), heart rate and rate of perceived exertion (RPE) would help determine which variables are optimal for prescription success. Identification of reliable methods to tailor PR for people with interstitial lung disease would enhance what is already known and potentially lead to best practice guideline development.
In accordance with the guidelines, this systematic review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) on 07 May 2024 (registration number CRD42024543174).
本综述旨在确定哪些心肺运动试验(CPET)衍生变量可用于为间质性肺疾病患者量身定制肺康复(PR)。由于存在众多独特的特征、亚组和表型,“一刀切”的方法并非对每个患者都有益。该领域尚无针对ILD的、量身定制的肺康复指南,且缺乏运动项目开发。这导致文献和临床实践中的成功率差异很大。
将检索MEDLINE、Embase、CINAHL、SPORTDiscus和Cochrane系统评价数据库,以识别利用CPET变量进行PR开发的研究。将使用针对单队列研究和随机对照研究的批判性评估技能计划(CASP)清单进行质量评估。
纳入研究中发现的关于峰值耗氧量(VO )、工作率(WR )、无氧阈值时的耗氧量(VO -AT)、心率和自觉用力程度(RPE)的主要结果,将有助于确定哪些变量对于处方成功最为理想。确定为间质性肺疾病患者量身定制PR的可靠方法,将丰富现有认知,并可能促成最佳实践指南的制定。
根据指南,本系统评价方案于2024年5月7日在国际前瞻性系统评价注册库(PROSPERO)注册(注册号CRD42024543174)。